Demant A/S (CPH:DEMANT)
201.80
+1.80 (0.90%)
Apr 29, 2026, 9:52 AM CET
Demant Employees
As of December 31, 2025, Demant had 26,704 total employees, including 23,450 full-time and 3,254 part-time employees. The number of employees increased by 4,065 or 17.96% compared to the previous year.
Employees
26,704
Change (1Y)
4,065
Growth (1Y)
17.96%
Revenue / Employee
916.02K DKK
Profits / Employee
61.61K DKK
Market Cap
42.18B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 26,704 | 4,065 | 17.96% | 23,450 | 3,254 |
| Dec 31, 2024 | 22,639 | 1,016 | 4.70% | 19,917 | 2,722 |
| Dec 31, 2023 | 21,623 | 1,053 | 5.12% | 21,623 | 0 |
| Dec 31, 2022 | 20,570 | 2,454 | 13.55% | 20,570 | 0 |
| Dec 31, 2021 | 18,116 | 1,525 | 9.19% | 18,116 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Nordisk | 69,505 |
| Coloplast | 16,983 |
| GN Store Nord | 7,371 |
| Ambu A/S | 5,200 |
| H. Lundbeck | 5,039 |
| Embla Medical | 4,195 |
| Genmab | 2,973 |
| ALK-Abelló | 2,613 |
Demant News
- 6 days ago - Reminder - Waterdrop (WDH) Goes Ex-Dividend Soon - Nasdaq
- 3 months ago - Demant Earnings Call Transcript: Q4 2025 - Transcripts
- 6 months ago - Demant Earnings Call Transcript: Q3 2025 - Transcripts
- 9 months ago - Demant Earnings Call Transcript: Q2 2025 - Transcripts
- 11 months ago - Demant Transcript: M&A Announcement - Transcripts
- 11 months ago - Demant Transcript: M&A Announcement (Media) - Transcripts
- 1 year ago - Demant Earnings Call Transcript: Q1 2025 - Transcripts
- 1 year ago - Demant Earnings Call Transcript: Q4 2024 - Transcripts